PRTA

Prothena (PRTA)

Prothena Corporation PLC

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PRTA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/29	05 : 05	Business Wire	Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/18	05 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/18	05 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/18	05 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/18	05 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/09	05 : 19	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/09	05 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/09	05 : 05	Business Wire	Prothena Reports First Quarter 2024 Financial Results and Business Highlights	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/02	05 : 05	Business Wire	Prothena to Report First Quarter 2024 Financial Results on May 8	NASDAQ:PRTA	Prothena Corporation PLC
2024/04/16	05 : 05	Business Wire	Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/06	11 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/06	11 : 01	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/06	06 : 05	Business Wire	Prothena to Participate in Upcoming Healthcare Conferences	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/05	06 : 05	Business Wire	Prothena Appoints David Ford to Newly Created Chief People Officer Position	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/01	11 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/01	11 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/01	11 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/01	11 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/01	11 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/01	11 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/01	11 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/01	11 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/01	11 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/02/23	07 : 29	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:PRTA	Prothena Corporation PLC
2024/02/23	06 : 56	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:PRTA	Prothena Corporation PLC
2024/02/22	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRTA	Prothena Corporation PLC
2024/02/22	06 : 05	Business Wire	Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate	NASDAQ:PRTA	Prothena Corporation PLC
2024/02/16	06 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRTA	Prothena Corporation PLC
2024/02/16	06 : 05	Business Wire	Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights	NASDAQ:PRTA	Prothena Corporation PLC
2024/02/15	02 : 16	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:PRTA	Prothena Corporation PLC